Algert Global LLC Cuts Stake in Maximus, Inc. $MMS

Key Points

• Algert Global LLC has significantly reduced its stake in Maximus, Inc. by 41.2%, owning approximately 109,941 shares valued at $7.5 million after selling 77,076 shares in the first quarter.
• Maximus, Inc. reported $2.16 earnings per share in its latest quarterly results, exceeding analysts' expectations and marking a 2.5% revenue increase year-over-year.
• The firm announced a quarterly dividend of $0.30 per share, which represents an annualized payout of $1.20 and a dividend yield of 1.4%.

Algert Global LLC lowered its stake in Maximus, Inc. (NYSE:MMS - Free Report) by 41.2% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 109,941 shares of the health services provider's stock after selling 77,076 shares during the quarter. Algert Global LLC owned about 0.19% of Maximus worth $7,497,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the company. LRI Investments LLC lifted its position in Maximus by 11.9% during the first quarter. LRI Investments LLC now owns 1,833 shares of the health services provider's stock valued at $125,000 after acquiring an additional 195 shares during the last quarter. Vestcor Inc raised its holdings in shares of Maximus by 2.3% in the first quarter. Vestcor Inc now owns 9,877 shares of the health services provider's stock worth $674,000 after buying an additional 223 shares during the last quarter. Cetera Investment Advisers raised its holdings in shares of Maximus by 5.8% in the first quarter. Cetera Investment Advisers now owns 4,519 shares of the health services provider's stock worth $308,000 after buying an additional 247 shares during the last quarter. UMB Bank n.a. raised its holdings in shares of Maximus by 70.2% in the first quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock worth $41,000 after buying an additional 250 shares during the last quarter. Finally, Nisa Investment Advisors LLC raised its holdings in shares of Maximus by 0.7% in the first quarter. Nisa Investment Advisors LLC now owns 39,936 shares of the health services provider's stock worth $2,723,000 after buying an additional 290 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Wall Street Zen cut shares of Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th. One analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, Maximus presently has a consensus rating of "Buy" and an average price target of $90.00.

Insiders Place Their Bets

In other Maximus news, Director Gayathri Rajan sold 7,913 shares of the business's stock in a transaction dated Friday, May 30th. The shares were sold at an average price of $72.38, for a total value of $572,742.94. Following the transaction, the director directly owned 14,205 shares in the company, valued at $1,028,157.90. The trade was a 35.78% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 1.60% of the company's stock.

Maximus Stock Performance

MMS traded up $1.5160 on Friday, reaching $86.9260. The stock had a trading volume of 517,681 shares, compared to its average volume of 568,640. Maximus, Inc. has a 12-month low of $63.77 and a 12-month high of $93.94. The company has a current ratio of 2.27, a quick ratio of 2.27 and a debt-to-equity ratio of 0.91. The business's 50-day moving average price is $74.16 and its two-hundred day moving average price is $70.99. The company has a market cap of $4.90 billion, a P/E ratio of 16.01 and a beta of 0.60.

Maximus (NYSE:MMS - Get Free Report) last released its earnings results on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.77. The business had revenue of $1.35 billion during the quarter, compared to analysts' expectations of $1.29 billion. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The company's quarterly revenue was up 2.5% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.74 earnings per share. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. Sell-side analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Sunday, August 31st. Investors of record on Friday, August 15th will be given a dividend of $0.30 per share. The ex-dividend date is Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.4%. Maximus's payout ratio is presently 22.10%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.